Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients

Strides For Life I: A Randomized Controlled Trial of Induction of Positive Affect to Increase Physical Activity in Early Stage Lung Cancer Survivors

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02755883

Enrollment

Registered

2016-04-29

Start date

2016-04-30

Completion date

2017-10-31

Last updated

2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Physical activity, non-small lung cancer, positive affect

Brief summary

This randomized controlled trial will evaluate, among 54 stage early stage lung cancer patients, whether a behavioral intervention versus an educational Control group results in improved function at 6-months.

Detailed description

This is a two arm randomized controlled trial that will evaluate, among 54 stage 1 non-small cell lung cancer patients, whether induction of positive affect vs. an educational Control group, results in improved function as assessed by the 6-minute Walk Test. Our primary outcome will be a within-patient change in the 6-Minute Walk Test at 6 months.

Interventions

BEHAVIORALPhysical activity plus positive affect

Subjects will be randomized to a physical activity goal and will receive the positive affect component.

BEHAVIORALPhysical activity plus education

Subjects will be randomized to a physical activity goal and will receive the educational component.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 110 Years

Healthy volunteers

Inclusion criteria

* Non-small cell lung cancer (Stage 1)

Exclusion criteria

1. Cognitive impairment 2. Inability to walk 3. \< 12 month anticipated survival 4. enrollment in other behavioral programs 5. lack of medical approval to participate 6. substance/alcohol dependence or participation in a substance abuse treatment program within 12 months 7. major psychiatric illness.

Design outcomes

Primary

Measure	Time frame
Kilocalories/week assessed by 6-minute walk test	1 month to 6 months

Secondary

Measure	Time frame	Description
Forced expiratory volume (FEV1)	1 month to 6 months	Pulmonary function test
Functional Assessment of Cancer Therapy- Lung (FACT-L14)	1 month to 6 months	Disease-specific quality of life
Activity expenditure (assessed by the Fit Bit Zip accelerometer)	1 month to 6 months	—
Maximal Oxygen Consumption (VO2 max)	1 month to 6 months	Pulmonary function test

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026